We developed an HIV testing dashboard to complement the HIV care continuum in selected high-risk populations. Using National HIV Behavioral Surveillance (NHBS) data, we examined trends in HIV testing and care for men who have sex with men (MSM), persons who inject drugs (PWID), and heterosexuals at elevated risk (HET).
INTRODUCTION
Initiated in 2003, the Center for Disease and Prevention's (CDC) National HIV Behavioral Surveillance (NHBS) system monitors HIV risk behaviors, testing, and prevention service use among populations most at risk of HIV infection: men who have sex with men (MSM), persons who inject drugs (PWID), and heterosexuals at elevated risk (HET). 1 Washington, DC began contributing data to NHBS in 2006 and has completed 3 rounds of data collection for each population. As the only continuous, routine HIV surveillance system in the United States that includes HIV-negative persons at risk, newly diagnosed HIV-positive, and selfreported positive (SRP) persons, NHBS provides a unique opportunity to examine patterns of HIV testing and HIV care among populations at risk for HIV in Washington, DC over time.
HIV testing is the gateway to the HIV prevention continuum including important interventions such as preexposure prophylaxis (PrEP) and combination prevention. 2 It also acts as the entry point to linkage to HIV care. Yet because of the nature of HIV core surveillance, it is difficult to know who is being tested for HIV, how many people are testing, and how frequently they are being tested. Nationally, among populations most at risk for HIV, high proportions report having ever been tested for HIV, but significant proportions are still not testing annually. [3] [4] [5] In Washington, DC, a city with high HIV prevalence, the DC Department of Health has increased access to HIV testing over the last 10 years, conducting 163,000 publicly funded HIV tests in 2014, a 4.3-fold increase since 2006. [6] [7] [8] [9] NHBS assesses lifetime and recent HIV testing in key populations, but these estimates have not been comprehensively examined locally to identify gaps in testing coverage and trends in testing over time.
In the realm of HIV care, the care continuum displays proportions of HIV-infected persons diagnosed, linked to and retained in care, and virally suppressed and is helpful in identifying gaps in care coverage among persons living with HIV. 6, 10 In 2014, the CDC estimated 40% of those diagnosed were engaged in HIV care, 37% were prescribed antiretroviral (ARV) treatment, and only 30% had achieved viral suppression. 11 Because persons who are aware of their HIV infection and virally suppressed are less likely to transmit HIV, high levels of coverage at each step are integral to HIV prevention and reduction of HIV-related morbidity and mortality. 12, 13 Both HIV testing and care are now seen as necessary components of HIV prevention, 2 yet few studies have examined these 2 side by side to present a wider view in a jurisdiction. We propose examining HIV testing and HIV prevalence as a testing "dashboard" to concisely display HIV testing behaviors and HIV prevalence among populations at high risk for HIV over time. Using NHBS data, we aimed to identify trends, gaps, and needs regarding both HIV testing and HIV care in community-based populations between 2007 and 2015 for MSM, PWID, and heterosexuals. . NHBS methods have been described elsewhere. 1 Briefly, cross-sectional behavioral and HIV testing data are collected in repeated, serial cross-sectional, community-based surveys among all 3 populations. Eligibility requirements included being $18 years old, a Washington, DC area resident, and able to complete the survey in English or Spanish. Conducting interviews in 3 populations also necessitated cycle-specific eligibility criteria. MSM had to be born and identify as male and report oral or anal sex with a male partner in the last year. PWID must have reported injection drug use in the last year, based on verification of visible injection site marks or the ability to describe injection practices. Heterosexuals at elevated risk for HIV in HET1 identified as male or female, reported vaginal or anal sex with an opposite sex partner in the last year, were 18-50 year old, and lived in high-risk areas, determined based on a combination of poverty and AIDS case rates. In the HET2 and HET3 cycles, participants must have identified as male or female, had an annual household income below federal poverty guidelines or a high school education or less, were 18-60 year old, and reported vaginal or anal sex with a person of the opposite sex in the past year.
METHODS

Sampling and Recruitment
NHBS uses 2 different recruitment methodologies, which have been described previously. 1, 14, 15 Venue-based sampling (VBS) is used for the MSM cycle and involves random time-space sampling. 14 Respondent-driven sampling (RDS) is used for the PWID and HET cycles. RDS is a chainreferral method that accesses hard to reach populations and provides estimates generalizable to the population of networks from which they are drawn. 15 
Data Collection and HIV Testing
Eligible and consenting participants completed an interviewer-administered survey and were offered a rapid HIV test. HIV testing was voluntary and was not required for study participation. All preliminary HIV reactive results and those self-reporting HIV-positive status were confirmed via western blot, except for the HET1 data collection cycle in which the preliminary rapid result was used. 16 The NHBS survey assessed demographic characteristics, sexual and drug use risk behaviors, HIV testing history, and engagement in care and ARV use for SRP participants. All activities were reviewed and approved by the George Washington University and DC Department of Health Institutional Review Boards.
Measures
Demographic and behavioral characteristics were assessed for each cycle including: age, gender, race, education, income, homelessness in the last year, injection drug use ever in the last year, and noninjection drug use in the last year.
The HIV testing dashboard presents proportions of NHBS participants ever tested for HIV (lifetime testing), tested for HIV in the last 12 months, tested HIV-positive, and newly positive. Being ever tested for HIV was assessed in the NHBS core questionnaire among all participants. HIV testing in the last year was calculated for those who self-reported HIVnegative or unknown status and was based on month and year of participant's last HIV test relative to the date of interview. HIV-positive status (ie, HIV prevalence) was calculated as the number of persons with a confirmed NHBS HIV-positive test result (with the exception of the HET1 cycle as previously noted-see Magnus et al 16 ) divided by the number of persons who completed HIV testing for NHBS. Newly identified HIVpositive status was defined as being self-reported HIV-negative or of unknown HIV status in the core questionnaire and having a positive NHBS HIV test result.
Persons who self-reported HIV-positive status during the survey were asked questions about HIV care engagement. Based on available data, we generated an abbreviated HIV care continuum using self-reported data which included the proportion of SRP participants who were engaged in care (both ever and in the last 12 months) and who were currently on ARVs. Self-reported viral load was not asked until 2015, so viral suppression was excluded from this analysis. Engagement in care in the last 12 months was calculated based on the self-reported month and year of participant's last appointment with an HIV provider relative to the interview date. Current ARV use was defined as having reported taking ARVs for HIV care at the time of interview. Not all SRP persons agreed to HIV testing or were confirmed HIV positive by western blot (eg, indeterminate result), so we assessed differences in the HIV continuum for SRP persons with and without serological confirmation. Although the number of unconfirmed SRP persons varied by cycle and year, HIV care continuum outcomes were not significantly different between those serologically confirmed and unconfirmed for all of the populations (data not shown). Therefore, we presented HIV care data for all SRP participants. The use of self-reported HIV care outcomes from NHBS is consistent with previous national publications. 17 
Data Analysis
Demographic characteristics were examined for each cycle. Descriptive statistics are presented for categorical variables, and medians and interquartile ranges are presented for continuous variables. To assess demographic differences across data collection years, x 2 tests were conducted for categorical variables and Wilcoxon rank-sum tests for continuous variables. For RDS cycles, the RDS Analysis Tool (RDSAT) version 8.1 was used to create sample weights to adjust for referral patterns, network size, and relationship to the recruiter in order to obtain population-based estimates that are unbiased to the underlying network. 18, 19 Data for the MSM cycles are unweighted because of lack of data on frequency of venue attendance across cycles. [20] [21] [22] Unweighted analysis of MSM cycle data is consistent with previous national and local publications. [23] [24] [25] [26] For the HIV testing dashboard, ever tested for HIV and HIV tested in the last 12 months were presented as proportions of the total cycle sample, whereas HIV-positive and newly positive were presented as proportions of those who completed NHBS HIV testing. Each variable in the abbreviated HIV care continuum for SRP participants was presented as the proportion of all SRP participants for that cycle. The HIV testing dashboard and care continuum were calculated separately for each population. Trends over time were assessed using the x 2 test for trend. To examine differences in HIV testing, data were analyzed by race (black/white/other) for MSM and gender (male/female) for PWID and HET. HIV care continuum data were analyzed by population. We did not assess between-population differences to focus on trends within each population over time. All analyses were completed using SAS version 9.3 (Cary, NC).
RESULTS
Over 10 years, a total of 4792 eligible participants completed a behavioral survey and were offered HIV testing. Table 1 
HIV Testing Dashboard
The HIV testing dashboard for MSM (Fig. 1) Among PWID sampled (Fig. 2) , being ever tested for HIV did not differ significantly over time, whereas HIV testing in the past year was significantly higher in 2015 compared with 2009 (78% vs. 66%, respectively P , 0.0001). Estimated HIV prevalence was 13% in both 2009 and 2012 and was significantly different in 2015 at 15% (P , 0.0001). Across most time points, a higher proportion of male PWID had ever been HIV tested than female PWID. Among female PWID, a significantly lower proportion reported ever testing for HIV in 2015 compared with 2009 and 2012 (85% vs. 91% and 100%, respectively, P = 0.045), but past year HIV testing was significantly higher in 2015 vs. 2009 (81% vs. 60%, respectively, P , 0.001). Estimated HIV prevalence among female PWID was significantly higher in later years (13% in 2009 vs. 17% in 2012 and 27% in 2015; P = 0.0005); the HIV prevalence for male PWID did not differ over time. Among sampled heterosexuals at elevated risk for HIV, the proportion who had ever been HIV tested remained stable from 2007 to 2013 (Fig. 3) (85%-89%, P = 0.12), whereas past year testing rose significantly (45%-73%, P , 0.001). HIV prevalence in HET overall ranged from 4% to 8% across years; the proportion newly diagnosed as HIV-positive decreased significantly between 2007 and 2013 (2%-0%, respectively; P = 0.003). Stratifying by gender, male and female HET participants both reported significant increases in past year testing between 2007 and 2013 (male: 40%-67%, P , 0.0001; female: 50%-76%, P , 0.0001). Estimated prevalence of newly identified HIV infections in both HET males and females decreased from 2% in 2007 to 0% in 2013, but this was only statistically significant among HET females (P = 0.04).
HIV Care Continuum
In Figure 4 , among SRP MSM, the proportion who had ever seen an HIV care provider was high but did not differ significantly across time (92%-96%, P = 0.36), as was the proportion who had seen an HIV care provider in the past 12 months (90%-92%, P = 0.68). Among SRP PWID, significantly higher proportions had ever been in care in 2012 and 2015 compared with 2009 (100% and 97% vs. 69%, respectively, P , 0.0001). Additionally, there were significant increases from 2009 to 2015 in the proportion who had seen a medical provider for HIV care in the past year (65% vs. 89%, P = 0.003) and on ARV treatment at the time of interview (43% vs. 76%, P = 0.0003). Among SRP HET participants, having seen a medical provider for HIV care in the past year increased from 51% in 2007 to 86% in 2013 (P = 0.007). Although currently being on ARV treatment was higher in 2007 compared with 2013 (60% vs. 90%, respectively; P = 0.045), ARV use in 2010 was particularly low at 28%.
DISCUSSION
We developed an HIV testing dashboard to provide key information on HIV testing coverage in high-risk populations to complement the HIV care continuum. The dashboard highlights gaps and trends in HIV testing and prevalence in Washington, DC from 2007 to 2015 and may also indicate the potential impact of expanded HIV testing programs. HIV testing, both lifetime and past year, was highest for all populations in the most recent cycles compared with the first cycle, suggesting important increases in HIV testing coverage over time. This reflects national trends in which MSM reported the highest proportions of past year HIV testing and HIV prevalence compared with PWID and HET. 3, 4, 27 Higher HIV prevalence was observed among MSM and PWID in later data collection years, and observed HIV prevalence was lower in later years among HET. The abbreviated care continuum showed that MSM also had higher levels of engagement in care, both ever and in the past year, and ARV use, compared with PWID and heterosexuals.
Among MSM, PWID, and heterosexuals, .80% reported ever testing for HIV, and there were significant increases over time in the proportion tested for HIV in the past year. An analysis among cities funded through CDC's Expanded HIV Testing Initiative found a similar increase in recent testing between 2008 and 2011 among MSM, 28 and Washington, DC reports among the highest levels of past year testing in all populations. 3, 4, 27 Over time, we observed successively higher proportions of engagement in care and ARV use among heterosexuals and PWID. This may suggest the increased identification of HIV-positive individuals who are linked into care as a result of the expansion of HIV testing and linkage services in Washington, DC in the past decade. 8, 18 In addition, much research and programming to increase HIV care engagement have been conducted in Washington, DC, which may also have contributed to increased proportions of HIV care engagement observed across all populations over time. 6, [29] [30] [31] [32] [33] [34] [35] Despite these promising trends, gaps in annual HIV testing and disparities in HIV prevalence persist in each key population, particularly among black MSM and women. Although Washington, DC has been successful in increasing HIV testing overall in these populations, 7 our findings among black MSM highlight the continued racial disparity in HIV prevalence among MSM, seen both nationally and in Washington, DC. 9, 36 In addition, differences in HIV prevalence persisted across time among women compared with men in both the HET and PWID cycles in Washington, DC. Participants in the PWID and HET cycles predominantly identify as black, which may partially explain these disparities, because black women continue to be highly affected by HIV. 37 Combined, these observed disparities signal the need for continued development and implementation of prevention interventions focusing on these highly impacted populations.
The National HIV/AIDS Strategy (NHAS) aims to increase retention in care and viral suppression among persons living with HIV. 38 Our findings suggest that Washington, DC has succeeded in increasing engagement in care among HIV-positive MSM, PWID, and heterosexuals in the past decade. Specifically, the NHAS aims to increase retention in HIV care to 90% for persons living with HIV by 2020. Among MSM surveyed in 2014 for NHBS, Washington, DC successfully achieved this goal and was close to 90% among heterosexuals and PWID based on data from 2013 and 2015, respectively. In the most recent data collection cycles, SRP MSM, PWID, and heterosexuals reported higher proportions of engagement in care and ARV use compared with national estimates, but it should be noted that there are methodological differences between the data used from NHBS and those from the National HIV Surveillance System and Medical Monitoring Project. 11 Although 10 years of behavioral surveillance data for 3 high-risk populations provide numerous insights into the spectrum of HIV testing and care, these findings should be considered in light of their limitations. First, although data for PWID and HET were RDS-weighted, data from the MSM cycles were unweighted because of lack of information on venue attendance; therefore, these data may not be representative of venue-attending MSM or MSM who do not attend venues because of the nature of the sampling scheme. While HIV status is confirmed by serologic testing, HIV testing and care data are based on self-report, and therefore they may be subject to recall and social desirability bias. Although interviewers were highly trained and routine data quality checks were conducted, there was the possibility of recording errors and intra-/interinterviewer differences in questionnaire administration. Although eligibility and recruitment criteria were consistent across PWID and MSM cycles, the eligibility and recruitment criteria differed slightly between HET1 and HET2 as noted previously. Lastly, the abbreviated HIV care continuum was based on a small sample size and does not include a measure of viral suppression.
CONCLUSIONS
The HIV testing dashboard provides a concise view of key HIV testing indicators in high-risk populations within a jurisdiction that are unique to NHBS data. Together with the abbreviated HIV care continuum, the dashboard provides a wider lens through which a more complete picture of HIV prevention and treatment activities can be viewed.
